THC reduces inflammation in the stomach and the severity of colitis by killing an enzyme in white blood cells.
That’s the conclusion of researchers from Austria and Germany.
“A huge amount of preclinical data suggests that gastrointestinal disease is highly amenable to treatment with Cannabis/cannabinoids,” according to the study, published in the April 2017 issue of The Expert Review of Gastroenterology & Hepatology.
In “Cannabinoids for treating inflammatory bowel diseases,” the authors say the use of cannabis among patients with IBD is substantial, with up to 17% reporting prior or current use for disease symptoms.
Cannabis is frequently used to alleviate diarrhea, abdominal pain and loss of appetite. Approximately 84% of cannabis users reported that it improves abdominal pain.
A third Cannabinoid Receptor was recently identified in the stomach and colon.
Clinical trails are currently underway.